Stem Cell Banking Market – Analysis and Forecast To 2024 | Cryo-Save AG, LifeCell International.

The global stem cell banking market is growing at a CAGR of 9.1% during the forecast period reaching USD 10.5 billion by 2024, due to the development of novel technologies of storage, preservation and processing. Stem cell banking is the method of accumulating cord blood, extorting and cryogenically freezing its stem cells for forthcoming use. Cord blood stem cells are used for treating blood diseases such as sickle cell disease, leukemia, and thalassemia. The global stem cell banking market is growing at a significant rate due to the development of novel technologies of storage, preservation and processing. The market has witnessed a high demand for placenta stem cells over the last few years, due to the increasing public awareness regarding the therapeutic prospective of stem cells.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/stem-cell-banking-market/request-sample

Growing global burden of major disease, increasing healthcare expenditure and public awareness related to the therapeutic potential of stem cells are also fueling the growth of the stem cell banking market. Moreover, it has gained immense popularity in emerging economies.

The strict regulatory framework and high operational and processing costs are the major challenges for the growth of stem cell banking market. Moreover, the socio-ethical issues involved in stem cell research such as destruction of human embryo and religious briefs are considered as the hindering factor for the market.

Asia-Pacific is observed to witness the fastest growth in the market. As the region comprises of largest population and the awareness for stem cell banking is increasing rapidly among them. In addition, increasing awareness on the therapeutic potential of stem cells, improving healthcare infrastructure are also creating a positive impact on the stem cell banking market growth in the region.

Read More: https://www.vynzresearch.com/healthcare/stem-cell-banking-market

Key players in the stem cell banking industry are investing in the development of innovative and advance products, which is strengthening their position in the market. In May 2018, Cordlife launched PlumCare DNA Advisor, to detect and manage genetic mutations associated with hereditary conditions in the Philippines. In addition, in December 2017, Cordlife had partnered with Eone-Diagnomics Genome Center (EDGC), a certified laboratory in South Korea, to offer non-invasive prenatal testing in Indonesia and the Philippines.

Cord Blood Registry Systems, Cordlife Group Limited, Cryo-Cell International, Cryo-Save AG, LifeCell International, StemCyte, ViaCord, Global Cord Blood, Smart Cells International, Vita34, and CryoHoldco are some of the key players offering products.

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: kundan@vynzresearch.com

Website: www.vynzresearch.com